Real-World Survival Outcomes Associated With First-Line Immunotherapy, Targeted Therapy, and Combination Therapy for Metastatic Clear Cell Renal Cell Carcinoma

IMPORTANCE: Clinical trials have shown an overall survival (OS) benefit associated with first-line immunotherapy (IT) and combination targeted therapy (TT) and IT regimens compared with TT among patients with metastatic clear cell renal cell carcinoma (RCC). Generalizability of these findings in a r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Netw Open
Main Authors: Chakiryan, Nicholas H., Jiang, Da David, Gillis, Kyle A., Green, Elizabeth, Hajiran, Ali, Hugar, Lee, Zemp, Logan, Zhang, Jingsong, Jain, Rohit K., Chahoud, Jad, Spiess, Philippe E., Sexton, Wade, Gilbert, Scott M., Manley, Brandon J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2021
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8150693/
https://ncbi.nlm.nih.gov/pubmed/34032854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2021.11329
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados